$KLIC
Kulicke and Soffa Industries Inc Stock $klic

$klic Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000005697822000024 Filed on February 03, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$460.9M	$267.9M
YoY Change	72.06%	77.69%
Cost Of Revenue	$237.7M	$146.4M
YoY Change	62.36%	79.73%
Gross Profit	$223.2M	$121.5M
YoY Change	83.76%	75.3%
Gross Profit Margin	48.44%	45.35%
Selling, General & Admin	$38.96M	$35.90M
YoY Change	8.52%	23.11%
% of Gross Profit	17.45%	29.55%
Research & Development	$33.17M	$31.54M
YoY Change	5.15%	8.52%
% of Gross Profit	14.86%	25.97%
Depreciation & Amortization	$5.339M	$5.147M
YoY Change	3.73%	74.53%
% of Gross Profit	2.39%	4.24%
Operating Expenses	$72.13M	$67.44M
YoY Change	6.95%	15.83%
Operating Profit	$151.1M	$54.04M
YoY Change	179.62%	387.92%
Interest Expense	$40.00K	$32.00K
YoY Change	25.0%	-95.16%
% of Operating Profit	0.03%	0.06%
Other Income/Expense, Net
YoY Change
Pretax Income	$151.5M	$54.66M
YoY Change	177.24%	317.58%
Income Tax	$17.94M	$6.298M
% Of Pretax Income	11.84%	11.52%
Net Earnings	$133.6M	$48.36M
YoY Change	176.26%	306.82%
Net Earnings / Revenue	28.99%	18.06%
Basic Earnings Per Share	$2.14	$0.78
Diluted Earnings Per Share	$2.11	$0.77
COMMON SHARES
Basic Shares Outstanding	62.39M shares	61.97M shares
Diluted Shares Outstanding	63.32M shares	62.74M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$808.5M	$576.7M
YoY Change	40.19%	-9.93%
Cash & Equivalents	$441.5M	$239.7M
Short-Term Investments	$407.0M	$337.0M
Other Short-Term Assets	$25.77M	$21.20M
YoY Change	21.53%	-12.03%
Inventory	$197.2M	$125.1M
Prepaid Expenses
Receivables	$431.6M	$226.7M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.463B	$949.6M
YoY Change	54.07%	-2.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$67.11M	$60.94M
YoY Change	10.13%	9.5%
Goodwill	$72.35M	$57.34M
YoY Change	26.18%	2.49%
Intangibles	$40.70M	$37.58M
YoY Change	8.32%	-5.48%
Long-Term Investments	$6.412M	$1.214M
YoY Change	428.17%	5.66%
Other Assets	$2.436M	$2.287M
YoY Change	6.52%	12.83%
Total Long-Term Assets	$241.5M	$197.2M
YoY Change	22.47%	3.51%
TOTAL ASSETS
Total Short-Term Assets	$1.463B	$949.6M
Total Long-Term Assets	$241.5M	$197.2M
Total Assets	$1.705B	$1.147B
YoY Change	48.64%	-1.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$148.8M	$89.36M
YoY Change	66.48%	76.85%
Accrued Expenses	$47.37M	$40.00M
YoY Change	18.44%	0.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$343.8M	$200.7M
YoY Change	71.31%	-23.41%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$14.60M	$13.42M
YoY Change	8.83%	37.54%
Total Long-Term Liabilities	$14.60M	$13.42M
YoY Change	8.83%	37.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$343.8M	$200.7M
Total Long-Term Liabilities	$14.60M	$13.42M
Total Liabilities	$497.4M	$339.2M
YoY Change	46.65%	-14.89%
SHAREHOLDERS EQUITY
Retained Earnings	$1.072B	$655.8M
YoY Change	63.4%	8.57%
Common Stock	$548.4M	$538.4M
YoY Change	1.85%	1.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$408.8M	$391.9M
YoY Change	4.32%	7.33%
Treasury Stock Shares	22.98M shares	23.31M shares
Shareholders Equity	$1.207B	$807.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.705B	$1.147B
YoY Change	48.64%	-1.22%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	$133.6M	$48.36M
YoY Change	176.26%	306.82%
Depreciation, Depletion And Amortization	$5.339M	$5.147M
YoY Change	3.73%	74.53%
Cash From Operating Activities	$95.87M	$58.64M
YoY Change	63.51%	315.85%
INVESTING ACTIVITIES
Capital Expenditures	$2.711M	$4.897M
YoY Change	-44.64%	-295.88%
Acquisitions
YoY Change
Other Investing Activities	$10.00M	$5.100M
YoY Change	96.08%	-103.95%
Cash From Investing Activities	$7.289M	$224.0K
YoY Change	3154.02%	-100.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$15.29M	$1.731M
YoY Change	783.07%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$24.08M	-$9.207M
YoY Change	161.51%	-176.09%
NET CHANGE
Cash From Operating Activities	$95.87M	$58.64M
Cash From Investing Activities	$7.289M	$224.0K
Cash From Financing Activities	-$24.08M	-$9.207M
Net Change In Cash	$78.70M	$51.54M
YoY Change	52.69%	-148.95%
FREE CASH FLOW
Cash From Operating Activities	$95.87M	$58.64M
Capital Expenditures	$2.711M	$4.897M
Free Cash Flow	$93.16M	$53.74M
YoY Change	73.37%	223.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-01-01
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000056978
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-01
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-1498399
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	23A Serangoon North Avenue 5
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-01-01
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	0-121
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	KULICKE AND SOFFA INDUSTRIES, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	PA
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	#01-01,
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Singapore
CY2022Q1	dei	Entity Address Country EntityAddressCountry	SG
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	554369
CY2022Q1	dei	City Area Code CityAreaCode	215
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	784-6000
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, Without Par Value
CY2022Q1	dei	Trading Symbol TradingSymbol	KLIC
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	62300428	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	441490000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	362788000	USD
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	367000000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	377000000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	687000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	687000	USD
CY2022Q1	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	431574000	USD
CY2021Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	421193000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	197234000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	167323000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25765000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	23586000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	1463063000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1351890000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67109000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67982000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39124000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41592000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	72353000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	72949000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	40702000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	42752000	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13332000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	15715000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	6412000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	6388000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2436000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2363000	USD
CY2022Q1	us-gaap	Assets Assets	1704531000	USD
CY2021Q4	us-gaap	Assets Assets	1601631000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	148769000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	154636000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5056000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4903000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	43828000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	30766000	USD
CY2022Q1	klic	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	146152000	USD
CY2021Q4	klic	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	161570000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	343805000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	351875000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	33371000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	32828000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	69618000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	69422000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14600000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14185000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	497355000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	35961000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	38084000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	506394000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	61931000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85364000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85364000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	62384000	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	548425000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	550117000	USD
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	22980000	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	23433000	shares
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	408788000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	400412000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1071550000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	948554000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4011000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3022000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1207176000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1095237000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1704531000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1601631000	USD
CY2022Q1	us-gaap	Revenues Revenues	460888000	USD
CY2021Q1	us-gaap	Revenues Revenues	267857000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	237650000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	146371000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	223238000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	121486000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38959000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35900000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33169000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31544000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	72128000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	67444000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	151110000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	54042000	USD
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	471000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	651000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	40000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	32000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	151541000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	54661000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17935000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6298000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	133606000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	48363000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.14
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.11
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.77
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62385000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61965000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63316000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62740000	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	133606000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	48363000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1665000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	7186000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	68000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	139000	USD
CY2022Q1	klic	Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent	-1733000	USD
CY2021Q1	klic	Comprehensive Income Loss Foreign Currency Transactionand Translationand Pensionand Other Post Retirement Benefits Netof Tax Portion Attributableto Parent ComprehensiveIncomeLossForeignCurrencyTransactionandTranslationandPensionandOtherPostRetirementBenefitsNetofTaxPortionAttributabletoParent	7047000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-989000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7763000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	132617000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	56126000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1095237000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	238000	USD
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	15380000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5074000	USD
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	10610000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	133606000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-989000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	132617000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1207176000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	757994000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	173000	USD
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1206000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3216000	USD
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	8687000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	48363000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7763000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	56126000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	807616000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	133606000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	48363000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5339000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5147000	USD
CY2022Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	5312000	USD
CY2021Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3389000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	33000	USD
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	1519000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	-48000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2926000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-568000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	31410000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	14000	USD
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	414000	USD
CY2021Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2230000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	10322000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	28608000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13115000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1551000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	856000	USD
CY2022Q1	klic	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-23278000	USD
CY2021Q1	klic	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	38983000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	13256000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2778000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-891000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-921000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	95874000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	58635000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2711000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4897000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	121000	USD
CY2022Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	89000000	USD
CY2021Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	80000000	USD
CY2022Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	99000000	USD
CY2021Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	85000000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7289000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	224000	USD
CY2022Q1	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	12000000	USD
CY2021Q1	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	USD
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	12000000	USD
CY2021Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	118000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	77000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	15286000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1731000	USD
CY2022Q1	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	8673000	USD
CY2021Q1	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	7399000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24077000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-9207000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-384000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1891000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	78702000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	51543000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	362788000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188127000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	441490000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	239670000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	40000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	32000	USD
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	2385000	USD
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	5246000	USD
CY2022Q1	us-gaap	Basis Of Accounting BasisOfAccounting	BASIS OF PRESENTATION<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (“we,” “us,” “our,” or the “Company”) with appropriate elimination of intercompany balances and transactions. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim consolidated condensed financial statements are unaudited and, in management's opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair presentation of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended October 2, 2021, filed with the Securities and Exchange Commission, which includes Consolidated Balance Sheets as of October 2, 2021 and October 3, 2020, and the related Consolidated Statements of Operations, Statements of Comprehensive Income, Changes in Shareholders' Equity and Cash Flows for each of the years in the three-year period ended October 2, 2021. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company's first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2022 quarters end on January 1, 2022, April 2, 2022, July 2, 2022 and October 1, 2022. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2021 quarters ended on January 2, 2021, April 3, 2021, July 3, 2021 and October 2, 2021. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Business</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designs, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company's operating results depend upon the capital and operating expenditures of semiconductor device manufacturers, integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), and other electronics manufacturers including automotive electronics suppliers worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry's demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, including those sold by the Company. These downturns and slowdowns have in the past adversely affected the Company's operating results. The Company believes such volatility will continue to characterize the industry and the Company's operations in the future.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company's assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the coronavirus (“COVID-19”) pandemic, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of January 1, 2022. While there was no material impact to our consolidated condensed financial statements as of and for the quarter ended January 1, 2022, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 that could materially impact our consolidated condensed financial statements in future reporting periods. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vulnerability to Certain Concentrations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which may subject the Company to concentrations of credit risk as of January 1, 2022 and October 2, 2021 consisted primarily of trade receivables. The Company manages credit risk associated with investments by investing its excess cash in highly rated debt instruments of the U.S. government and its agencies, financial institutions, and corporations. The Company has established investment guidelines relative to diversification and maturities designed to maintain safety and liquidity. These guidelines are periodically reviewed and modified as appropriate.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's trade receivables result primarily from the sale of semiconductor equipment, related accessories and replacement parts, and tools to a relatively small number of large manufacturers in a highly concentrated industry. Write-offs of uncollectible accounts have historically not been material. The Company actively monitors its customers' financial strength to reduce the risk of loss, including as a result of COVID-19. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's products are complex and require raw materials, components and subassemblies having a high degree of reliability, accuracy and performance. The Company relies on subcontractors to manufacture many of these components and subassemblies and it relies on sole source suppliers for some important components and raw material inventory.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Remeasurement</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's business is transacted in U.S. dollars; however, the functional currencies of some of the Company's subsidiaries are their local currencies. In accordance with ASC No. 830, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASC 830”), for a subsidiary of the Company that has a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net income, but are accumulated in the cumulative translation adjustment account as a separate component of shareholders' equity (accumulated other comprehensive income). The tax effect of currency translation adjustments related to unremitted foreign earnings no longer deemed to be indefinitely reinvested outside the U.S. is reflected in the determination of the Company’s net income or other comprehensive income (“OCI”). Gains and losses resulting from foreign currency transactions are included in the determination of net income. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operations are exposed to changes in foreign currency exchange rates due to transactions denominated in currencies other than the location's functional currency. The Company is also exposed to foreign currency fluctuations that impact the remeasurement of net monetary assets of those operations whose functional currency, the U.S. dollar, differs from their respective local currencies, most notably in Israel, Singapore and Switzerland. In addition to net monetary remeasurement, the Company has exposures related to the translation of subsidiary financial statements from their functional currency, the local currency, into its reporting currency, the U.S. dollar, most notably in the Netherlands, China, Taiwan, Japan and Germany. The Company's U.S. operations also have foreign currency exposure due to net monetary assets denominated in currencies other than the U.S. dollar.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s primary objective for holding derivative financial instruments is to manage the fluctuation in foreign exchange rates and accordingly is not speculative in nature. The Company’s international operations are exposed to changes in foreign exchange rates as described above. The Company has established a program to monitor the forecasted transaction currency risk to protect against foreign exchange rate volatility. Generally, the Company uses foreign exchange forward contracts in these hedging programs. These instruments, which have maturities of up to twelve months, are recorded at fair value and are included in prepaid expenses and other current assets, or accrued expenses and other current liabilities. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounting policy for derivative financial instruments is based on whether they meet the criteria for designation as a cash flow hedge. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction is referred to as a cash flow hedge. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument’s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain / (loss) from the effective portion of the hedge as a component of accumulated other comprehensive income / (loss) and reclassify it into earnings in the same period in which the hedged transaction affects earnings and in the same line item on the Consolidated Condensed Statement of Operations as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the Consolidated Condensed Statement of Cash Flows in the same section as the underlying item, primarily within cash flows from operating activities. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The hedge effectiveness of these derivative instruments is evaluated by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a cash flow hedge is discontinued because it is no longer probable that the original hedged transaction will occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income / (loss) into earnings. Subsequent gain / (loss) on the related derivative instrument is recognized into earnings in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash equivalents. Cash equivalents are measured at fair value based on Level 1 measurement, or quoted market prices, as defined by ASC No. 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests in equity securities in companies to promote business and strategic objectives. Equity investments are measured and recorded as follows:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-marketable equity securities are equity securities without readily determinable fair value that are measured and recorded using a measurement alternative that measures the securities at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Doubtful Accounts</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains allowances for doubtful accounts for estimated losses resulting from its customers' failure to make required payments. If the financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to make payments, including as a result of COVID-19, additional allowances may be required. If global or regional economic conditions deteriorate or political conditions were to change in some of the countries where the Company does business, including as a result of COVID-19, it could have a significant impact on the results of operations, and the Company's ability to realize the full value of its accounts receivable.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost (on a first-in, first-out basis) or net realizable value. The Company generally provides reserves for obsolete inventory and for inventory considered to be in excess of demand. Demand is generally defined as 18 months forecasted future consumption for equipment, 24 months forecasted future consumption for spare parts, and 12 months forecasted future consumption for tools. Forecasted consumption is based upon internal projections, historical sales volumes, customer order activity and a review of consumable inventory levels at customers' facilities. The Company communicates forecasts of its future consumption to its suppliers and adjusts commitments to those suppliers accordingly. If required, the Company reserves the difference between the carrying value of its inventory and the lower of cost or net realizable value, based upon projections about future consumption, and market conditions. If actual market conditions are less favorable than projections, additional inventory reserves may be required.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory reserve provision for certain subsidiaries is determined based on management's estimate of future consumption for equipment and spare parts. This estimate is based on historical sales volumes, internal projections and market developments and trends. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are carried at cost. The cost of additions and those improvements which increase the capacity or lengthen the useful lives of assets are capitalized, while repair and maintenance costs are expensed as incurred. Depreciation and amortization are provided on a straight-line basis over the estimated useful lives as follows: buildings 25 years; machinery, equipment, furniture and fittings 3 to 10 years; toolings 1 year; and leasehold improvements are based on the shorter of the life of lease or life of asset. Purchased computer software costs related to business and financial systems are amortized over a five-year period on a straight-line basis. Land is not depreciated.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation of Long-Lived Assets </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC No. 360, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property, Plant & Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 360"), the Company's definite lived intangible assets and property, plant and equipment are tested for impairment based on undiscounted cash flows when triggering events occur, and if impaired, written-down to fair value based on either discounted cash flows or appraised values. ASC 360 also provides a single accounting model for long-lived assets to be disposed of by sale and establishes additional criteria that would have to be met to classify an asset as held for sale. The carrying amount of an asset or asset group is not recoverable to the extent it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. Estimates of future cash flows used to test the recoverability of a long-lived asset or asset group must incorporate the entity's own assumptions about its use of the asset or asset group and must factor in all available evidence.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 360 requires that long-lived assets be tested for recoverability whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Such events include significant under-performance relative to historical internal forecasts or projected future operating results; significant changes in the manner of use of the assets; significant negative industry or economic trends; or significant changes in market capitalization. During the three months ended January 1, 2022, no "triggering" events occurred. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting for Impairment of Goodwill</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC No. 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> requires goodwill and other intangible assets with indefinite lives to be reviewed for impairment annually, or more frequently if circumstances indicate a possible impairment. We assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, after assessing the qualitative factors, a company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying value, then performing the impairment test is unnecessary. However, if a company concludes otherwise, then it is required to perform the goodwill impairment test. The Company's impairment test is performed by comparing the fair value of a reporting unit with its carrying value, and determining if the carrying amount exceeds its fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the annual evaluation, the Company performs an impairment test of its goodwill in the fourth quarter of each fiscal year to coincide with the completion of its annual forecasting and refreshing of its business outlook processes. On an ongoing basis, the Company monitors if a “triggering” event has occurred that may have the effect of reducing the fair value of a reporting unit below its respective carrying value. Adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a non-cash impairment charge in the future. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment assessments inherently involve judgment as to the assumptions made about the expected future cash flows and the impact of market conditions on those assumptions. Future events and changing market conditions may impact the assumptions as to prices, costs, growth rates or other factors that may result in changes in the estimates of future cash flows. Although the Company believes the assumptions that it has used in testing for impairment are reasonable, significant changes in any one of the assumptions could produce a significantly different result. Indicators of potential impairment, including significant and unforeseen customer losses, a significant adverse change in legal factors or in the business climate, a significant adverse action or assessment by a regulator, a significant stock price decline or unanticipated competition may lead the Company to perform interim goodwill impairment assessments. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information on goodwill and other intangible assets, please refer to Note 3 below.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC No. 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue from sales of our products, including sales to our distributors, at a point in time, generally upon shipment or delivery to the customer or distributor, depending upon the terms of the sales order. Control is considered transferred when title and risk of loss pass, when the customer becomes obligated to pay and, where applicable, when the customer has accepted the products or upon expiration of the acceptance period. For sales to distributors, payment is due on our standard commercial terms and is not contingent upon the distributors' resale of the products. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our business is subject to contingencies related to customer orders, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Right of Return: A large portion of our revenue comes from the sale of equipment used in the semiconductor assembly process. Other product sales relate to consumable products, which are sold in high-volume quantities, and are generally maintained at low stock levels at the customer's facility. Customer returns have historically represented a very small percentage of customer sales on an annual basis.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Warranties: Our equipment is generally shipped with a one-year warranty against manufacturing defects. We establish reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management's estimate of future expenses, including product parts replacement, freight charges and labor costs expected to be incurred to correct manufacturing defects during the warranty period.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Conditions of Acceptance: Sales of our consumable products generally do not have customer acceptance terms. In certain cases, sales of our equipment have customer acceptance clauses which may require the equipment to perform in accordance with agreed specifications, customer specifications or subject to satisfactory installation at the customer's facility. In such cases, if the terms of acceptance are satisfied at our facility prior to shipment, the revenue for the equipment will be recognized upon shipment. If the terms of acceptance are satisfied at our customers' facilities, the revenue for the equipment will not be recognized until acceptance, which is typically obtained after installation and testing, is received from the customer.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue is generally recognized over time as the services are performed. For the three months ended January 1, 2022, and January 2, 2021, the service revenue is not material. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures revenue based on the amount of consideration we expect to be entitled to in exchange for products or services. Any variable consideration such as sales incentives are recognized as a reduction of net revenue at the time of revenue recognition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The length of time between invoicing and payment is not significant under our payment terms. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined our contracts generally do not include a significant financing component.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs billed to customers are recognized in net revenue. Shipping and handling costs paid by the Company are included in cost of sales.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company charges research and development costs associated with the development of new products to expense when incurred. In certain circumstances, pre-production machines that the Company intends to sell are carried as inventory until sold.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC No. 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, deferred income taxes are determined using the balance sheet method. The Company records a valuation allowance to reduce its deferred tax assets to the amount expected, on a more likely than not basis, to be realized. While the Company has considered future taxable income and ongoing tax planning strategies in assessing the need for the valuation allowance, if it were to determine that it would be able to realize its deferred tax assets in the future in excess of its net recorded amount, an adjustment to deferred tax assets would increase income in the period when such determination is made. Likewise, should the Company determine it would not be able to realize all or part of its deferred tax assets in the future, an adjustment to deferred tax assets would decrease income in the period when such determination is made.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the amount of unrecognized tax benefit with respect to uncertain tax positions taken or expected to be taken on its income tax returns in accordance with ASC No. 740 Topic 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes, General</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASC 740.10”). Under ASC 740.10, the Company utilizes a two-step approach for evaluating uncertain tax positions. Step one, or recognition, requires a company to determine if the weight of available evidence indicates a tax position is more likely than not to be sustained upon examination solely based on its technical merit. Step two, or measurement, is based on the largest amount of benefit, which is more likely than not to be realized on settlement with the taxing authority, including resolution of related appeals or litigation processes, if any.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity-Based Compensation </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for equity-based compensation under the provisions of ASC No. 718,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation - Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASC 718”). ASC 718 requires the recognition of the fair value of the equity-based compensation in net income. Compensation expense associated with Relative TSR Performance Share Units is determined using a Monte-Carlo valuation model, and compensation expense associated with time-based and Growth Performance Share Units is determined based on the number of shares granted and the fair value on the date of grant. Please refer to Note 10 for a summary of the terms of these performance-based awards. The fair value of the Company's stock option awards is estimated using a Black-Scholes option valuation model. The fair value of equity-based awards is amortized over the vesting period of the award and the Company elected to use the straight-line method for awards granted after the adoption of ASC 718. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share (“EPS”) are calculated in accordance with ASC No. 260,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Earnings per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Basic EPS include only the weighted average number of common shares outstanding during the period. Diluted EPS include the weighted average number of common shares and the dilutive effect of stock options, restricted stock awards, performance share units and restricted share units outstanding during the period, when such instruments are dilutive. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring Charges</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring charges may consist of voluntary or involuntary severance-related charges, asset-related charges and other costs due to exit activities. We recognize voluntary termination benefits when an employee accepts the offered benefit arrangement. We recognize involuntary severance-related charges depending on whether the termination benefits are provided under an ongoing benefit arrangement or under a one-time benefit arrangement. If the former, we recognize the charges once they are probable and the amounts are estimable. If the latter, we recognize the charges once the benefits have been communicated to employees.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and clarify and amend existing guidance. We adopted this ASU in the first quarter of fiscal 2022. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span>. The amendments in this ASU affect a wide variety of Topics in the Codification and improve the consistency of the Codification by including all disclosure guidance in the appropriate disclosure section (Section 50). We adopted this ASU in the first quarter of fiscal 2022. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.
CY2022Q1	us-gaap	Fiscal Period FiscalPeriod	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span>Each of the Company's first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2022 quarters end on January 1, 2022, April 2, 2022, July 2, 2022 and October 1, 2022. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2021 quarters ended on January 2, 2021, April 3, 2021, July 3, 2021 and October 2, 2021.
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company's assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</span></div>Due to the coronavirus (“COVID-19”) pandemic, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of January 1, 2022. While there was no material impact to our consolidated condensed financial statements as of and for the quarter ended January 1, 2022, these estimates may change, as new events occur and additional information is obtained, as well as other factors related to COVID-19 that could materially impact our consolidated condensed financial statements in future reporting periods.
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	130143000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	126069000	USD
CY2021Q4	klic	Accrued Liabilities For Commission And Professional Fees Current AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent	8673000	USD
CY2022Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	6313000	USD
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	6190000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67109000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67982000	USD
CY2022Q1	srt	Payables To Customers PayablesToCustomers	87568000	USD
CY2021Q4	srt	Payables To Customers PayablesToCustomers	72478000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	36000000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	66531000	USD
CY2022Q1	klic	Accrued Liabilities For Commission And Professional Fees Current AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent	10610000	USD
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	367000000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	377000000	USD
CY2022Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	102886000	USD
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	94493000	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	70626000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	55866000	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	47865000	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	40006000	USD
CY2022Q1	us-gaap	Inventory Gross InventoryGross	221377000	USD
CY2021Q4	us-gaap	Inventory Gross InventoryGross	190365000	USD
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	24143000	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	23042000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	197234000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	167323000	USD
CY2022Q1	us-gaap	Land Land	2182000	USD
CY2021Q4	us-gaap	Land Land	2182000	USD
CY2022Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	23402000	USD
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	23314000	USD
CY2022Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	30127000	USD
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	30054000	USD
CY2022Q1	klic	Equipment And Software Gross EquipmentAndSoftwareGross	41259000	USD
CY2021Q4	klic	Equipment And Software Gross EquipmentAndSoftwareGross	40945000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	90107000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	87994000	USD
CY2022Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10175000	USD
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	9562000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	197252000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	194051000	USD
CY2022Q1	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	5000	USD
CY2021Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	31000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5656000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7667000	USD
CY2022Q1	klic	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	146152000	USD
CY2021Q4	klic	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	161570000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	72949000	USD
CY2022Q1	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-596000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	72353000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	40702000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	42752000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3892000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	6146000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6146000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6146000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6146000	USD
CY2022Q1	klic	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	12226000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	40702000	USD
CY2022Q1	us-gaap	Cash Cash	262962000	USD
CY2022Q1	klic	Cash Unrealized Gains CashUnrealizedGains	0	USD
CY2022Q1	klic	Cash Unrealized Losses CashUnrealizedLosses	0	USD
CY2022Q1	klic	Cash Estimated Fair Value CashEstimatedFairValue	262962000	USD
CY2022Q1	klic	Cashand Cash Equivalents Amortized Cost CashandCashEquivalentsAmortizedCost	441509000	USD
CY2022Q1	klic	Cashand Cash Equivalents Gross Unrealized Gain CashandCashEquivalentsGrossUnrealizedGain	0	USD
CY2022Q1	klic	Cashand Cash Equivalents Gross Unrealized Loss CashandCashEquivalentsGrossUnrealizedLoss	19000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	441490000	USD
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	367000000	USD
CY2022Q1	klic	Availableforsale Securities Shortterm Investments Gross Unrealized Gain AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedGain	0	USD
CY2022Q1	klic	Availableforsale Securities Shortterm Investments Gross Unrealized Loss AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedLoss	0	USD
CY2022Q1	klic	Availableforsale Securities Shortterm Investments Fair Value Disclosure AvailableforsaleSecuritiesShorttermInvestmentsFairValueDisclosure	367000000	USD
CY2022Q1	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestments	808509000	USD
CY2022Q1	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Gain CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedGain	0	USD
CY2022Q1	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Loss CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedLoss	19000	USD
CY2022Q1	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Fair Value Disclosure CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsFairValueDisclosure	808490000	USD
CY2021Q4	us-gaap	Cash Cash	269201000	USD
CY2021Q4	klic	Cash Unrealized Gains CashUnrealizedGains	0	USD
CY2021Q4	klic	Cash Unrealized Losses CashUnrealizedLosses	0	USD
CY2021Q4	klic	Cash Estimated Fair Value CashEstimatedFairValue	269201000	USD
CY2021Q4	klic	Cashand Cash Equivalents Amortized Cost CashandCashEquivalentsAmortizedCost	362806000	USD
CY2021Q4	klic	Cashand Cash Equivalents Gross Unrealized Gain CashandCashEquivalentsGrossUnrealizedGain	0	USD
CY2021Q4	klic	Cashand Cash Equivalents Gross Unrealized Loss CashandCashEquivalentsGrossUnrealizedLoss	18000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	362788000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	377000000	USD
CY2021Q4	klic	Availableforsale Securities Shortterm Investments Gross Unrealized Gain AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedGain	0	USD
CY2021Q4	klic	Availableforsale Securities Shortterm Investments Gross Unrealized Loss AvailableforsaleSecuritiesShorttermInvestmentsGrossUnrealizedLoss	0	USD
CY2021Q4	klic	Availableforsale Securities Shortterm Investments Fair Value Disclosure AvailableforsaleSecuritiesShorttermInvestmentsFairValueDisclosure	377000000	USD
CY2021Q4	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestments	739806000	USD
CY2021Q4	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Gain CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedGain	0	USD
CY2021Q4	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Gross Unrealized Loss CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsGrossUnrealizedLoss	18000	USD
CY2021Q4	klic	Cash Cash Equivalents Restricted Cash Restricted Cash Equivalentsand Short Term Investments Fair Value Disclosure CashCashEquivalentsRestrictedCashRestrictedCashEquivalentsandShortTermInvestmentsFairValueDisclosure	739788000	USD
CY2022Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	6412000	USD
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	6388000	USD
CY2022Q1	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	6412000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni And Without Readily Determinable Fair Value EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue	6388000	USD
CY2022Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	43715000	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	128000	USD
CY2021Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	57682000	USD
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	616000	USD
CY2022Q1	us-gaap	Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1 DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1	P12M
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.058
CY2022Q1	klic	Leases Numberof Options To Extend LeasesNumberofOptionsToExtend	0	extend_options
CY2022Q1	us-gaap	Lease Cost LeaseCost	2054000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	1867000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1885000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1746000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y3M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y7M6D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.058
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	5616000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6648000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6221000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5884000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5046000	USD
CY2022Q1	klic	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	24798000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	54213000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13196000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	41017000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5056000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	35961000	USD
CY2021Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.17
CY2022Q1	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	8700000	USD
CY2022Q1	us-gaap	Pension Contributions PensionContributions	508000	USD
CY2021Q1	us-gaap	Pension Contributions PensionContributions	419000	USD
CY2017Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	100000000	USD
CY2018Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	200000000	USD
CY2019Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	300000000	USD
CY2020Q3	klic	Stock Repurchase Program Authorized Amount Additional Amount StockRepurchaseProgramAuthorizedAmountAdditionalAmount	100000000	USD
CY2020Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	400000000	USD
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	276000	shares
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	15400000	USD
CY2022Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	116600000	USD
CY2022Q1	klic	Relative Total Shareholder Return Average Stock Price Calculation Period RelativeTotalShareholderReturnAverageStockPriceCalculationPeriod	P90D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	523000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	689000	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5312000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3401000	USD
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5312000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3401000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	15596000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2950000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-31366000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-9850000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	43998000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress	11112000	USD
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	28228000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4212000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	133606000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	133606000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	48363000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	48363000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62385000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62385000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61965000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61965000	shares
CY2022Q1	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	931000	USD
CY2021Q1	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	775000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63316000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62740000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.14
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.14
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
CY2022Q1	klic	Earnings Per Share Diluted Adjustment EarningsPerShareDilutedAdjustment	-0.03
CY2021Q1	klic	Earnings Per Share Diluted Adjustment EarningsPerShareDilutedAdjustment	-0.01
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.11
CY2022Q1	klic	Inventory Purchase Obligation Future Minimum Payments Due In Two Years InventoryPurchaseObligationFutureMinimumPaymentsDueInTwoYears	266774000	USD
CY2022Q1	klic	Inventory Purchase Obligation Future Minimum Payments Due In Three Years InventoryPurchaseObligationFutureMinimumPaymentsDueInThreeYears	0	USD
CY2022Q1	klic	Inventory Purchase Obligation Future Minimum Payments Due In Four Years InventoryPurchaseObligationFutureMinimumPaymentsDueInFourYears	0	USD
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.77
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17935000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6298000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.118
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.115
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q1	klic	Inventory Purchase Obligation Future Minimum Payments Due In Five Years InventoryPurchaseObligationFutureMinimumPaymentsDueInFiveYears	0	USD
CY2022Q1	klic	Inventory Purchase Obligation Future Minimum Payments Due Thereafter InventoryPurchaseObligationFutureMinimumPaymentsDueThereafter	0	USD
CY2022Q1	us-gaap	Revenues Revenues	460888000	USD
CY2021Q1	us-gaap	Revenues Revenues	267857000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	151110000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	54042000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	2876000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	3687000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	4056000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	3189000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1283000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1958000	USD
CY2022Q1	klic	Period Of Warranty For Manufacturing Defects PeriodOfWarrantyForManufacturingDefects	P1Y
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	16961000	USD
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	9576000	USD
CY2022Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	3968000	USD
CY2021Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	5300000	USD
CY2022Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	3819000	USD
CY2021Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2740000	USD
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	17110000	USD
CY2021Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	12136000	USD
CY2022Q1	klic	Inventory Purchase Obligation Future Minimum Payments Due InventoryPurchaseObligationFutureMinimumPaymentsDue	471258000	USD
CY2022Q1	klic	Inventory Purchase Obligation Future Minimum Payments Due Current InventoryPurchaseObligationFutureMinimumPaymentsDueCurrent	204484000	USD

Files In Submission

Name	View Source	Status
0000056978-22-000024-index-headers.html	Edgar Link	pending
0000056978-22-000024-index.html	Edgar Link	pending
0000056978-22-000024.txt	Edgar Link	pending
0000056978-22-000024-xbrl.zip	Edgar Link	pending
a10qq12022ex311.htm	Edgar Link	pending
a10qq12022ex312.htm	Edgar Link	pending
a10qq12022ex321.htm	Edgar Link	pending
a10qq12022ex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
klic-20220101.htm	Edgar Link	pending
klic-20220101.xsd	Edgar Link	pending
klic-20220101_cal.xml	Edgar Link	unprocessable
klic-20220101_def.xml	Edgar Link	unprocessable
klic-20220101_htm.xml	Edgar Link	completed
klic-20220101_lab.xml	Edgar Link	unprocessable
klic-20220101_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KLIC
Kulicke and Soffa Industries Inc Stock $klic

2022 Q1 Form 10-Q Financial Statement

#000005697822000024 Filed on February 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KLIC Kulicke and Soffa Industries Inc Stock $klic

2022 Q1 Form 10-Q Financial Statement

#000005697822000024 Filed on February 03, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KLIC
Kulicke and Soffa Industries Inc Stock $klic